BCAB Cash-Secured Put Strategy

BCAB (BioAtla, Inc.), in the Healthcare sector, (Biotechnology industry), listed on NASDAQ.

BioAtla, Inc., a clinical stage biopharmaceutical company, develops specific and selective antibody-based therapeutics for the treatment of solid tumor cancer. Its lead product candidate is BA3011, a conditionally active biologic (CAB) antibody-drug conjugate (ADC) for soft tissue and bone sarcoma tumors, non-small cell lung cancer (NSCLC), and ovarian cancer. It also develops BA3021, a CAB ADC for multiple solid tumor types, including NSCLC, melanoma, and ovarian cancer; and BA3071, which is a CAB anti-cytotoxic T-lymphocyte-associated antigen 4 antibody for renal cell carcinoma, NSCLC, small cell lung cancer, hepatocellular carcinoma, melanoma, bladder cancer, gastric cancer, and cervical cancer. BioAtla, Inc. was founded in 2007 and is based in San Diego, California.

BCAB (BioAtla, Inc.) trades in the Healthcare sector, specifically Biotechnology, with a market capitalization of approximately $5.2M, a beta of 0.79 versus the broader market, a 52-week range of 3.92-71.5, average daily share volume of 40K, a public-listing history dating back to 2020, approximately 61 full-time employees. These structural characteristics shape how BCAB stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.

A beta of 0.79 places BCAB roughly in line with broader market moves, so the strategy payoff and realized volatility track the index-equivalent baseline.

What is a cash-secured put on BCAB?

A cash-secured put sells an out-of-the-money put while holding cash equal to the strike-times-100 obligation, keeping the premium when the underlying stays above the strike.

Current BCAB snapshot

As of May 15, 2026, spot at $4.28, ATM IV 59.20%, IV rank 8.41%, expected move 16.97%. The cash-secured put on BCAB below is built from the same end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 63-day expiry.

Why this cash-secured put structure on BCAB specifically: BCAB IV at 59.20% is on the cheap side of its 1-year range, which means a premium-selling BCAB cash-secured put collects less credit per unit of strike-width risk, with a market-implied 1-standard-deviation move of approximately 16.97% (roughly $0.73 on the underlying). The 63-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated BCAB expiries trade a higher absolute premium for lower per-day decay. Position sizing on BCAB should anchor to the underlying notional of $4.28 per share and to the trader's directional view on BCAB stock.

BCAB cash-secured put setup

The BCAB cash-secured put below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With BCAB near $4.28, the first option leg uses a $4.07 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed BCAB chain at a 63-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 BCAB shares for the stock leg in covered calls and collars).

ActionTypeStrike / BasisPremium (est)
Sell 1Put$4.07N/A

BCAB cash-secured put risk and reward

Net Premium / Debit
N/A
Max Profit (per contract)
Unbounded
Max Loss (per contract)
Unbounded
Breakeven(s)
None on modeled curve
Risk / Reward Ratio
N/A

Max profit equals premium times 100; max loss equals strike minus premium times 100 (at zero, assuming assignment). Breakeven is strike minus premium.

BCAB cash-secured put payoff curve

Modeled P&L at expiration across a range of underlying prices for the cash-secured put on BCAB. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.

When traders use cash-secured put on BCAB

Cash-secured puts on BCAB earn premium while a trader waits to acquire BCAB stock at a target strike below the current quote; most attractive when IV is rich and the trader is comfortable owning BCAB.

BCAB thesis for this cash-secured put

The market-implied 1-standard-deviation range for BCAB extends from approximately $3.55 on the downside to $5.01 on the upside. A BCAB cash-secured put lets a trader earn premium while waiting to acquire BCAB at the strike price; the strategy is most attractive when the trader is comfortable holding the underlying at that level and IV is rich enough to compensate for the assignment risk. Current BCAB IV rank near 8.41% sits in the lower third of its 1-year distribution, where IV often re-expands toward the mean; this favors premium-buying structures and disadvantages premium-selling structures on BCAB at 59.20%. As a Healthcare name, BCAB options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to BCAB-specific events.

BCAB cash-secured put positions are structurally neutral to slightly bullish; the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. BCAB positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move BCAB alongside the broader basket even when BCAB-specific fundamentals are unchanged. Short-premium structures like a cash-secured put on BCAB carry tail risk when realized volatility exceeds the implied move; review historical BCAB earnings reactions and macro stress periods before sizing. Always rebuild the position from current BCAB chain quotes before placing a trade.

Frequently asked questions

What is a cash-secured put on BCAB?
A cash-secured put on BCAB is the cash-secured put strategy applied to BCAB (stock). The strategy is structurally neutral to slightly bullish: A cash-secured put sells an out-of-the-money put while holding cash equal to the strike-times-100 obligation, keeping the premium when the underlying stays above the strike. With BCAB stock trading near $4.28, the strikes shown on this page are snapped to the nearest listed BCAB chain strike and the premiums come straight from the end-of-day bid/ask midpoint.
How are BCAB cash-secured put max profit and max loss calculated?
Max profit equals premium times 100; max loss equals strike minus premium times 100 (at zero, assuming assignment). Breakeven is strike minus premium. For the BCAB cash-secured put priced from the end-of-day chain at a 30-day expiry (ATM IV 59.20%), the computed maximum profit is unbounded per contract and the computed maximum loss is unbounded per contract. Live intraday quotes will differ as the chain moves through the trading session.
What is the breakeven for a BCAB cash-secured put?
The breakeven for the BCAB cash-secured put priced on this page is no defined breakeven on the modeled curve at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current BCAB market-implied 1-standard-deviation expected move is approximately 16.97%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
When should you consider a cash-secured put on BCAB?
Cash-secured puts on BCAB earn premium while a trader waits to acquire BCAB stock at a target strike below the current quote; most attractive when IV is rich and the trader is comfortable owning BCAB.
How does current BCAB implied volatility affect this cash-secured put?
BCAB ATM IV is at 59.20% with IV rank near 8.41%, which is on the low end of its 1-year range. Premium-buying structures (long call, long put, debit spreads) are relatively cheap in this regime; premium-selling structures collect less credit per unit risk.

Related BCAB analysis